University Library
  • Login
A gateway to Melbourne's research publications
Minerva Access is the University's Institutional Repository. It aims to collect, preserve, and showcase the intellectual output of staff and students of the University of Melbourne for a global audience.
View Item 
  • Minerva Access
  • Medicine, Dentistry & Health Sciences
  • Melbourne Medical School
  • Surgery (RMH)
  • Surgery (RMH) - Research Publications
  • View Item
  • Minerva Access
  • Medicine, Dentistry & Health Sciences
  • Melbourne Medical School
  • Surgery (RMH)
  • Surgery (RMH) - Research Publications
  • View Item
JavaScript is disabled for your browser. Some features of this site may not work without it.

    Csk-homologous kinase (Chk) is an efficient inhibitor of Src-family kinases but a poor catalyst of phosphorylation of their C-terminal regulatory tyrosine

    Thumbnail
    Download
    published version (3.007Mb)

    Citations
    Scopus
    Web of Science
    Altmetric
    4
    5
    Author
    Advani, G; Lim, YC; Catimel, B; Lio, DSS; Ng, NLY; Chueh, AC; Tran, M; Anasir, MI; Verkade, H; Zhu, H-J; ...
    Date
    2017-08-07
    Source Title
    Cell Communication and Signaling
    Publisher
    BIOMED CENTRAL LTD
    University of Melbourne Author/s
    Lio, Sio; Verkade, Heather; Griffin, Michael; Cheng, Heung; Chueh, Anderly; Ang, Ching-Seng; Catimel, Bruno; Zhu, Hongjian; Advani, Gahana Ravi; LIM, YA CHEE
    Affiliation
    Surgery (RMH)
    Biochemistry and Molecular Biology
    Medical Biology (W.E.H.I.)
    Medicine and Radiology
    Bio21
    Metadata
    Show full item record
    Document Type
    Journal Article
    Citations
    Advani, G., Lim, Y. C., Catimel, B., Lio, D. S. S., Ng, N. L. Y., Chueh, A. C., Tran, M., Anasir, M. I., Verkade, H., Zhu, H. -J., Turk, B. E., Smithgall, T. E., Ang, C. -S., Griffin, M. & Cheng, H. -C. (2017). Csk-homologous kinase (Chk) is an efficient inhibitor of Src-family kinases but a poor catalyst of phosphorylation of their C-terminal regulatory tyrosine. CELL COMMUNICATION AND SIGNALING, 15 (1), https://doi.org/10.1186/s12964-017-0186-x.
    Access Status
    Open Access
    URI
    http://hdl.handle.net/11343/256610
    DOI
    10.1186/s12964-017-0186-x
    Abstract
    BACKGROUND: C-terminal Src kinase (Csk) and Csk-homologous kinase (Chk) are the major endogenous inhibitors of Src-family kinases (SFKs). They employ two mechanisms to inhibit SFKs. First, they phosphorylate the C-terminal tail tyrosine which stabilizes SFKs in a closed inactive conformation by engaging the SH2 domain in cis. Second, they employ a non-catalytic inhibitory mechanism involving direct binding of Csk and Chk to the active forms of SFKs that is independent of phosphorylation of their C-terminal tail. Csk and Chk are co-expressed in many cell types. Contributions of the two mechanisms towards the inhibitory activity of Csk and Chk are not fully clear. Furthermore, the determinants in Csk and Chk governing their inhibition of SFKs by the non-catalytic inhibitory mechanism are yet to be defined. METHODS: We determined the contributions of the two mechanisms towards the inhibitory activity of Csk and Chk both in vitro and in transduced colorectal cancer cells. Specifically, we assayed the catalytic activities of Csk and Chk in phosphorylating a specific peptide substrate and a recombinant SFK member Src. We employed surface plasmon resonance spectroscopy to measure the kinetic parameters of binding of Csk, Chk and their mutants to a constitutively active mutant of the SFK member Hck. Finally, we determined the effects of expression of recombinant Chk on anchorage-independent growth and SFK catalytic activity in Chk-deficient colorectal cancer cells. RESULTS: Our results revealed Csk as a robust enzyme catalysing phosphorylation of the C-terminal tail tyrosine of SFKs but a weak non-catalytic inhibitor of SFKs. In contrast, Chk is a poor catalyst of SFK tail phosphorylation but binds SFKs with high affinity, enabling it to efficiently inhibit SFKs with the non-catalytic inhibitory mechanism both in vitro and in transduced colorectal cancer cells. Further analyses mapped some of the determinants governing this non-catalytic inhibitory mechanism of Chk to its kinase domain. CONCLUSIONS: SFKs are activated by different upstream signals to adopt multiple active conformations in cells. SFKs adopting these conformations can effectively be constrained by the two complementary inhibitory mechanisms of Csk and Chk. Furthermore, the lack of this non-catalytic inhibitory mechanism accounts for SFK overactivation in the Chk-deficient colorectal cancer cells.

    Export Reference in RIS Format     

    Endnote

    • Click on "Export Reference in RIS Format" and choose "open with... Endnote".

    Refworks

    • Click on "Export Reference in RIS Format". Login to Refworks, go to References => Import References


    Collections
    • Minerva Elements Records [53102]
    • Bio21 - Research Publications [308]
    • Medicine and Radiology - Research Publications [3320]
    • Medical Biology - Research Publications [1415]
    • Biochemistry and Molecular Biology - Research Publications [1075]
    • Surgery (RMH) - Research Publications [347]
    Minerva AccessDepositing Your Work (for University of Melbourne Staff and Students)NewsFAQs

    BrowseCommunities & CollectionsBy Issue DateAuthorsTitlesSubjectsThis CollectionBy Issue DateAuthorsTitlesSubjects
    My AccountLoginRegister
    StatisticsMost Popular ItemsStatistics by CountryMost Popular Authors